Jiangsu Kanion Pharmaceutical Co.,Ltd.’s Net Profit Rose 35% in First Three Quarters of 2022

Jiangsu Kanion Pharmaceutical Co.,Ltd. (江苏康缘药业股份有限公司) (600557.SH) reported a net profit of 284 million yuan in the first three quarters of 2022, up 35% year-on-year.

Meanwhile, the company posted 3.1 billion yuan in revenue, up 21% year-on-year.

At the end of the reporting period, it had 6.2 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 22.6%.